PROFUND ADVISORS LLC – Neurocrine Biosciences, Inc. Transaction History
PROFUND ADVISORS LLC portfolio value:
$1.44M
portfolio value
PROFUND ADVISORS LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.63% | -512 shares | 69K | $106.21 | 13.58K |
| Q2 2022 | share | Decrease | -9.52% | -1.48K shares | -86K | $97.48 | 14.09K |
| Q1 2022 | share | Decrease | -9.82% | -1.69K shares | -11K | $93.75 | 15.57K |
| Q4 2021 | share | Decrease | -13.24% | -2.63K shares | -439K | $84.63 | 17.27K |
| Q3 2021 | share | Decrease | -5.83% | -1.23K shares | -148K | $95.91 | 19.91K |
| Q2 2021 | share | Decrease | -2.03% | -437 shares | -41K | $97.32 | 21.14K |
| Q1 2021 | share | Increase | +13.34% | 2.54K shares | 274K | $97.25 | 21.58K |
| Q4 2020 | share | Increase | +9.85% | 1.70K shares | 158K | $95.85 | 19.04K |
| Q3 2020 | share | Decrease | -15.78% | -3.24K shares | -844K | $96.16 | 17.33K |
| Q2 2020 | share | Increase | +18.92% | 3.27K shares | 1.01M | $122 | 20.57K |
| Q1 2020 | share | Decrease | -26.73% | -6.31K shares | -1.04M | $86.55 | 17.30K |
| Q4 2019 | share | Increase | +12.06% | 2.54K shares | 640K | $107.49 | 23.61K |
| Q3 2019 | share | Decrease | -6.28% | -1.41K shares | 0 | $90.11 | 21.07K |
| Q2 2019 | share | Decrease | -11.13% | -2.81K shares | -330K | $84.43 | 22.48K |
| Q1 2019 | share | Increase | +1.55% | 387 shares | 450K | $88.1 | 25.30K |
| Q4 2018 | share | Decrease | -19.43% | -6.01K shares | -2.02M | $71.41 | 24.91K |
| Q3 2018 | share | Increase | +10.81% | 3.01K shares | 1.06M | $122.95 | 30.92K |
| Q2 2018 | share | Decrease | -4.77% | -1.39K shares | 311K | $98.24 | 27.91K |
| Q1 2018 | share | Decrease | -9.58% | -3.10K shares | -84K | $82.93 | 29.31K |
| Q4 2017 | share | Decrease | -11.17% | -4.07K shares | 279K | $77.59 | 32.41K |
| Q3 2017 | share | Increase | +8.60% | 2.88K shares | 690K | $61.28 | 36.49K |
| Q2 2017 | share | Decrease | -5.40% | -1.91K shares | 8K | $46 | 33.60K |
| Q1 2017 | share | Decrease | -7.38% | -2.83K shares | 54K | $43.3 | 35.52K |
| Q4 2016 | share | Decrease | -13.66% | -6.06K shares | -766K | $38.7 | 38.35K |
| Q3 2016 | share | Increase | +3.20% | 1.37K shares | 294K | $50.64 | 44.42K |
| Q2 2016 | share | Decrease | -8.45% | -3.97K shares | 96K | $45.45 | 43.04K |
| Q1 2016 | share | Decrease | -18.76% | -10.85K shares | -1.41M | $39.55 | 47.01K |